Area of research
Molecular Biology · Oncology
Research interest
Research focused on Wnt signaling pathway and GSK-3, with related work in Curcumin, Coronavirus disease 2019 (COVID-19), Doxorubicin. Notable publications include 'Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs', 'Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer', and 'Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells'.
498O INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma
Cancer therapy and treatments during COVID-19 era
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells